Coverage Policies

Aetna

Tumor Markers

Blue Cross Blue Shield of Alabama

Molecular Markers in Fine Needle Aspirates of the Thyroid

Blue Shield of California

Molecular Markers in Fine Needle Aspirates of the Thyroid

Cigna

Tumor Profiling, Gene Expression Assays and Molecular Diagnostic Testing for Hematology/Oncology Indications

Emblem Health

Gene Expression Profiling

UHC Oxford

Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions

WellMark Blue Cross Blue Shield

Molecular Markers in Fine Needle Aspirates of the Thyroid

LCD

Local Coverage Determination (LCD): Biomarkers for Oncology (L35396)

ThyGeNEXT® and ThyraMIR® have been reviewed by the BlueCross BlueShield Association’s Evidence Street which found that clinical input from specialty societies and physicians at academic centers support use for individuals with nodule(s) with an indeterminate FNA finding…[testing] would provide a clinical meaningful improvement in net health outcome.
–From Medical Policy 2.04.78, Molecular Markers in Fine Needle Aspiration of the Thyroid